Studying the effect of Some Hematological Parameters on a cohort of female individuals afflicted with breast cancer in The National Cancer Center in AL- Najaf AL- Ashraf Province

Authors

  • Rabab Ali Al-Mosawi Directorat education in Najef
  • Ebtesam Mohsen Al-Azawi

DOI:

https://doi.org/10.36320/ajb/v16.i1.14503

Keywords:

Complete Blood count, RBC, WBC, PLT, Breast Cancer

Abstract

           The current study aims to shed light on the importance of blood standards in determining abnormality score values in studying the disease for patients with breast cancer (BC) and comparing them with healthy people.                                                            

     The study included (50) women with breast cancer at different stages of the disease, with an average age ranging from (35 - 75) years. The study also included (25) healthy women with characteristics consistent with the previous group, and this group was classified as a control group.                                                                                    

     Samples for this study were collected for the period (from the first of January to the end of June of 2023). They were collected from patients attending the National Educational Center for Oncology in Najaf Governorate and who were diagnosed clinically and laboratory. The results of blood tests showed average values of RBC, HB, HCT, MCV, MCH, MCHC, PLT, RDW-SD, RDW- CV, MPV, PCT, WBC, and LYM. The current results showed significant differences in some parameters below the significance level (P ≤0.05). While no significant differences appeared in some other parameters. This study demonstrated the importance of blood standards as useful markers and methods that help in distinguishing between individuals afflicted with breast cancer and individuals in a state of good health. people.                                                                                                                      

     Patients with BC may have significant changes in various blood parameters. Blood parameters must be tested regularly for early diagnosis of the disease and the necessary follow-up is performed.  

Downloads

Download data is not yet available.

References

D. W. Kufe et al., “Cancer Medicine; ed.; BC Decker,” Inc. Lewiston, NY, 2003.

T. Byers, “Reducing the risk of cancer with healthy food choices and physical activity,” CA Cancer J. Clin, vol. 52, pp. 92–119, 2002. DOI: https://doi.org/10.3322/canjclin.52.2.92

J. Varlotto and M. A. Stevenson, “Anemia, tumor hypoxemia, and the cancer patient,” Int. J. Radiat. Oncol. Biol. Phys., vol. 63, no. 1, pp. 25–36, 2005. DOI: https://doi.org/10.1016/j.ijrobp.2005.04.049

F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal, “Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,” CA. Cancer J. Clin., vol. 68, no. 6, pp. 394–424, 2018. DOI: https://doi.org/10.3322/caac.21492

G. Roshandel et al., “Cancer incidence in Iran in 2014: results of the Iranian National Population-based Cancer Registry,” Cancer Epidemiol., vol. 61, pp. 50–58, 2019.

R. Dolatkhah et al., “Breast cancer survival and incidence: 10 years cancer registry data in the Northwest, Iran,” Int. J. Breast Cancer, vol. 2020, 2020. DOI: https://doi.org/10.1155/2020/1963814

M.-C. Wang et al., “Impacts of demographic and laboratory parameters on key hematological indices in an adult population of southern Taiwan: A cohort study,” PLoS One, vol. 13, no. 8, p. e0201708, 2018. DOI: https://doi.org/10.1371/journal.pone.0201708

L. O. Ali, “Study effect of breast cancer on some hematological and biochemical parameters in Babylon Province, Iraq,” J. Pharm. Biol. Sci., vol. 9, no. 3, pp. 20–24, 2014. DOI: https://doi.org/10.9790/3008-09352024

L. Koochakzadeh et al., “Establishing normal ranges of hematological parameters from an Iranian healthy population: A population-based cross-sectional study of hospital data,” Acta Med. Iran., pp. 571–576, 2018.

L. Chen, X. Kong, C. Yan, Y. Fang, and J. Wang, “The research progress on the prognostic value of the common hematological parameters in peripheral venous blood in breast cancer,” Onco. Targets. Ther., pp. 1397–1412, 2020. DOI: https://doi.org/10.2147/OTT.S227171

S. Khan, S. A. Khoso, S. Memon, A. Adeel, and G. Nabi, “Study of some Hematological parameters as Biomarker for breast Cancer population of Sindh,” Sindh Univ. Res. Journal-SURJ (Science Ser., vol. 49, no. 1, 2017.

L. Pietrzyk, Z. Plewa, M. Denisow-Pietrzyk, R. Zebrowski, and K. Torres, “Diagnostic power of blood parameters as screening markers in gastric cancer patients,” Asian Pacific J. Cancer Prev., vol. 17, no. 9, pp. 4433–4437, 2016.

A. Akinbami et al., “Full blood count pattern of pre-chemotherapy breast cancer patients in Lagos, Nigeria,” Casp. J. Intern. Med., vol. 4, no. 1, p. 574, 2013.

H. Sun, C. Yin, Q. Liu, F. Wang, and C. Yuan, “Clinical significance of routine blood test-associated inflammatory index in breast cancer patients,” Med. Sci. Monit. Int. Med. J. Exp. Clin. Res., vol. 23, p. 5090, 2017. DOI: https://doi.org/10.12659/MSM.906709

A. P. S. Rana, M. Kaur, B. Zonunsanga, A. Puri, and A. S. Kuka, “Preoperative peripheral blood count in breast carcinoma: predictor of prognosis or a routine test,” Int. J. Breast Cancer, vol. 2015, 2015. DOI: https://doi.org/10.1155/2015/964392

S. A. Ufelle et al., “Some hematological parameters in pre-and post-surgery breast cancer patients in Enugu, Nigeria,” Int J Cur Bio Med Sci, vol. 2, no. 1, pp. 188–190, 2012.

D. U. Boehm et al., “Prognostic impact of haemoglobin levels in breast cancer,” Anticancer Res., vol. 27, no. 2, pp. 1223–1226, 2007.

R. Farooq et al., “Role of hematological parameters in diagnosis and prognosis of gastric carcinoma in Kashmir, India,” Int Res J Pharm, vol. 4, no. 8, pp. 134–137, 2013. DOI: https://doi.org/10.7897/2230-8407.04824

Y. Kemal, G. Demirag, B. Baş, S. Önem, F. Teker, and İ. Yücel, “The value of red blood cell distribution width in endometrial cancer,” Clin. Chem. Lab. Med., vol. 53, no. 5, pp. 823–827, 2015. DOI: https://doi.org/10.1515/cclm-2014-0699

J. Chen, J. Wu, X. Lv, Q. Yang, J. Chen, and D. Zhang, “The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer,” PLoS One, vol. 15, no. 8, p. e0237947, 2020. DOI: https://doi.org/10.1371/journal.pone.0237947

N. Takahashi et al., “Causes of macrocytic anemia among 628 patients: mean corpuscular volumes of 114 and 130 fL as critical markers for categorization,” Int. J. Hematol., vol. 104, pp. 344–357, 2016. DOI: https://doi.org/10.1007/s12185-016-2043-x

Downloads

Published

2024-04-30

How to Cite

Al-Mosawi, R. A., & Al-Azawi, E. M. (2024). Studying the effect of Some Hematological Parameters on a cohort of female individuals afflicted with breast cancer in The National Cancer Center in AL- Najaf AL- Ashraf Province . Al-Kufa University Journal for Biology, 16(1), 82-86. https://doi.org/10.36320/ajb/v16.i1.14503

Share